Anti-IL-20

anti-IL-20 antibody · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Anti-IL-20, covering 2017-02-09 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis [Phase 1]